# Aclarion Inc. (ACON)

Source: https://www.quantisnow.com/company/ACON
Generated: 2026-11-09T17:37:53.370Z

- Ticker: ACON
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: 2022
- SEC CIK: 0001635077
- Website: https://www.aclarion.com

## About

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

## Latest ACON news and filings

- 2026-11-05 21:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Aclarion Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-aclarion-inc-6776996)
- 2026-10-22 11:00 UTC [Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs](https://www.quantisnow.com/insight/aclarion-announces-new-real-world-publication-nociscan-validated-by-strong-agreement-6754281)
- 2026-10-20 11:00 UTC [Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026](https://www.quantisnow.com/insight/aclarion-publishes-ceo-shareholder-letter-highlighting-continued-scan-volume-growth-6751357)
- 2026-10-13 11:00 UTC [Conference Announcement] [Aclarion to Present at the 20th Annual LD Micro Main Event](https://www.quantisnow.com/insight/aclarion-to-present-at-the-20th-annual-ld-micro-main-6744030)
- 2026-10-08 11:00 UTC [Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment](https://www.quantisnow.com/insight/aclarion-broadens-clarity-trial-enrollment-criteria-to-accelerate-enrollment-6740979)
- 2026-09-29 11:00 UTC [Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites](https://www.quantisnow.com/insight/aclarion-welcomes-nyu-langone-health-to-clarity-trial-network-now-6728308)
- 2026-08-20 11:00 UTC [Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site](https://www.quantisnow.com/insight/aclarion-announces-addition-of-university-of-arizona-college-of-medicine-6689301)
- 2026-08-19 12:30 UTC [Insider Buy] [Director Williams Amanda M bought $15,990 worth of shares (5,857 units at $2.73), increasing direct ownership by 29% to 25,857 units (SEC Form 4)](https://www.quantisnow.com/insight/director-williams-amanda-m-bought-15990-worth-of-shares-5857-6687917)
- 2026-08-18 12:30 UTC [Insider Buy] [CFO Gould Gregory A bought $24,500 worth of shares (10,000 units at $2.45), increasing direct ownership by 20% to 60,000 units (SEC Form 4)](https://www.quantisnow.com/insight/cfo-gould-gregory-a-bought-24500-worth-of-shares-10000-6686009)
- 2026-08-17 12:30 UTC [Insider Buy] [Chief Executive Officer Ness Brent bought $12,091 worth of shares (5,234 units at $2.31), increasing direct ownership by 5% to 111,534 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-ness-brent-bought-12091-worth-of-shares-6684461)
- 2026-08-17 12:30 UTC [Insider Buy] [Director Bond Ryan bought $50,059 worth of shares (21,122 units at $2.37), increasing direct ownership by 38% to 76,122 units (SEC Form 4)](https://www.quantisnow.com/insight/director-bond-ryan-bought-50059-worth-of-shares-21122-units-6684458)
- 2026-08-17 12:30 UTC [Insider Buy] [Director Wesemann William bought $5,031 worth of shares (2,150 units at $2.34), increasing direct ownership by 10% to 23,713 units (SEC Form 4)](https://www.quantisnow.com/insight/director-wesemann-william-bought-5031-worth-of-shares-2150-units-6684453)
- 2026-08-17 12:30 UTC [Insider Buy] [Director Neal David K bought $18,000 worth of shares (7,500 units at $2.40), increasing direct ownership by 33% to 30,002 units (SEC Form 4)](https://www.quantisnow.com/insight/director-neal-david-k-bought-18000-worth-of-shares-7500-6684452)
- 2026-08-12 11:00 UTC [Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process](https://www.quantisnow.com/insight/aclarion-receives-notice-of-allowance-for-patent-advancing-accuracy-and-6676915)
- 2026-08-06 13:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Aclarion Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-aclarion-inc-6667810)
- 2026-08-04 11:00 UTC [Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology](https://www.quantisnow.com/insight/aclarion-announces-nociscan-now-available-at-goodman-campbell-brain-spine-6660903)
- 2026-07-29 11:00 UTC [Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026](https://www.quantisnow.com/insight/aclarion-publishes-ceo-shareholder-letter-highlighting-progress-for-first-half-6652560)
- 2026-07-21 11:00 UTC [Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice](https://www.quantisnow.com/insight/aclarion-announces-presentation-of-two-abstracts-highlighting-nociscans-growing-role-6643123)
- 2026-07-09 12:00 UTC [SEC Form S-8] [SEC Form S-8 filed by Aclarion Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-aclarion-inc-6632428)
- 2026-07-07 11:00 UTC [Aclarion Announces Texas Spine Care Center as New CLARITY Site](https://www.quantisnow.com/insight/aclarion-announces-texas-spine-care-center-as-new-clarity-site-6629340)
- 2026-06-12 20:30 UTC [SEC Form 4] [Chief Strategy Officer Bond Ryan was granted 55,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-strategy-officer-bond-ryan-was-granted-55000-shares-sec-6600712)
- 2026-06-12 20:30 UTC [SEC Form 4] [Executive Chairman Thramann Jeffrey John was granted 100,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/executive-chairman-thramann-jeffrey-john-was-granted-100000-shares-sec-6600700)
- 2026-06-12 20:30 UTC [SEC Form 4] [Chief Financial Officer Gould Gregory A was granted 50,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-gould-gregory-a-was-granted-50000-shares-6600699)
- 2026-06-12 20:30 UTC [SEC Form 4] [Director Sequira Amanda Mae was granted 20,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-sequira-amanda-mae-was-granted-20000-shares-sec-form-6600698)
- 2026-06-12 20:30 UTC [SEC Form 4] [Director Breidbart Scott was granted 20,000 shares, increasing direct ownership by 353% to 25,664 units (SEC Form 4)](https://www.quantisnow.com/insight/director-breidbart-scott-was-granted-20000-shares-increasing-direct-ownership-6600696)
- 2026-06-12 20:30 UTC [SEC Form 4] [Director Wesemann William was granted 20,000 shares, increasing direct ownership by 1,280% to 21,563 units (SEC Form 4)](https://www.quantisnow.com/insight/director-wesemann-william-was-granted-20000-shares-increasing-direct-ownership-6600693)
- 2026-06-12 20:30 UTC [SEC Form 4] [Director Deitsch Stephen was granted 20,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-deitsch-stephen-was-granted-20000-shares-sec-form-4-6600692)
- 2026-06-12 20:30 UTC [SEC Form 4] [Director Neal David K was granted 20,000 shares, increasing direct ownership by 799% to 22,502 units (SEC Form 4)](https://www.quantisnow.com/insight/director-neal-david-k-was-granted-20000-shares-increasing-direct-6600690)
- 2026-06-12 20:30 UTC [SEC Form 4] [Chief Executive Officer Ness Brent was granted 100,000 shares, increasing direct ownership by 1,587% to 106,300 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-ness-brent-was-granted-100000-shares-increasing-6600685)
- 2026-06-10 11:00 UTC [Conference Announcement] [Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub](https://www.quantisnow.com/insight/aclarion-to-present-at-the-planet-microcap-las-vegas-powered-6596300)
- 2026-06-09 11:00 UTC [Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform](https://www.quantisnow.com/insight/aclarion-partners-with-pria-healthcare-to-advance-reimbursement-and-commercial-6594464)
- 2026-06-08 11:05 UTC [Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal](https://www.quantisnow.com/insight/aclarion-rejects-echo-lake-capitals-unsolicited-acquisition-proposal-6592501)
- 2026-06-08 11:00 UTC [Leadership Update] [Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting](https://www.quantisnow.com/insight/aclarion-stockholders-approve-all-proposals-at-2026-annual-meeting-6592473)
- 2026-06-04 20:49 UTC [SEC Form 8-K] [Aclarion Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/aclarion-inc-filed-sec-form-8-k-submission-of-matters-to-6589799)
- 2026-06-03 10:00 UTC [Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation](https://www.quantisnow.com/insight/aclarion-adds-institute-of-neuro-innovation-to-support-nociscan-growth-6585573)
- 2026-06-01 10:00 UTC [Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study](https://www.quantisnow.com/insight/aclarion-technology-demonstrates-potential-beyond-surgical-planning-in-new-immune-biomarker-6580308)
- 2026-05-28 18:49 UTC [Aclarion, Inc. Comments on Echo Lake Capital's Letter and Unsolicited Proposal](https://www.quantisnow.com/insight/aclarion-inc-comments-on-echo-lake-capitals-letter-and-unsolicited-6576821)
- 2026-05-28 12:00 UTC [Market Insight] [Echo Lake Capital Offers To Acquire Aclarion Inc.](https://www.quantisnow.com/insight/echo-lake-capital-offers-to-acquire-aclarion-inc-6576143)
- 2026-05-13 20:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Aclarion Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-aclarion-inc-6551278)
- 2026-05-12 22:53 UTC [Insider Buy] [Director Breidbart Scott bought $18,012 worth of shares (5,664 units at $3.18) (SEC Form 4)](https://www.quantisnow.com/insight/director-breidbart-scott-bought-18012-worth-of-shares-5664-units-6549144)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ACON
- Earnings history: https://www.quantisnow.com/earnings/ACON
- Dividend history: https://www.quantisnow.com/dividends/ACON
- Insider transactions: https://www.quantisnow.com/insiders/ACON
- Options chain: https://www.quantisnow.com/options/ACON
- SEC 8-K filings only: https://www.quantisnow.com/company/ACON/8-k
- RSS and alerts for ACON: https://www.quantisnow.com/docs/rss-feeds.md